From: Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer
Parameter | Risk ratio | 95Â % CI | p value |
---|---|---|---|
Age at surgery | Â | Â | Â |
 <65 years | 1 |  |  |
 >65 years | 1.573 | 0.907–2.729 | 0.107 |
Gender | Â | Â | Â |
 Female | 1 |  |  |
 Male | 1.125 | 0.563–2.247 | 0.739 |
Primary tumor | Â | Â | Â |
 T1–3 | 1 |  |  |
 T4 | 6.289 | 3.425–11.49 | <0.001 |
Lymph node metastasis | Â | Â | |
 N0 | 1 |  |  |
 N1 | 5.812 | 2.088–16.39 | <0.001 |
Lymphatic invasion | Â | Â | |
 Negative | 1 |  |  |
 Positive | 5.917 | 1.812–19.23 | 0.003 |
Venous invasion | Â | Â | Â |
 Negative | 1 |  |  |
 Positive | 3.135 | 1.541–6.369 | 0.002 |
Double-positive immunostaining | Â | ||
 Negative | 1 |  |  |
 Positive | 2.387 | 1.115–5.102 | 0.025 |